Express Press Release Distribution

Accounting
Advertising
Aerospace
Agriculture
Apparel & Fashion
Automotive
Biotech
Chemicals
Computers
Construction
Consumer Services
Defense
Education
Electronics
Energy
Entertainment
Environment
Financial
Food & Beverage
Government
Healthcare
Human Resources
Industrial
International Trade
Internet & Online
Law
Management
Marketing
Media
Non Profit
Pharmaceuticals
Real Estate
Retail
Semiconductors
Small Business
Software
Sports
Telecommunications
Transportation / Logistics
Travel

EPR Archived News

Archived News 2012
~ April
~ March
~ February
~ January

Archived News 2011
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2010
Archived News 2009
Archived News 2008
Archived News 2007
Archived News 2006
Archived News 2005
Archived News 2004

 

Dr Karim Dabbagh, Director of Pharmacology at Roche to present at GTCbio`s 3rd Protein Kinase in Drug Discovery Conference on May 5-6, 2008 in San Diego, CA

Released on: March 20, 2008, 11:17 am

Press Release Author: GTCbio

Industry: Biotech

Press Release Summary: Dr. Karim Dabbagh the Director of Pharmacology at Hoffmann-La
Roche will present at GTCbio's 3rd Protein Kinase in Drug Discovery Conference on
May 5-6, 2008 in San Diego, CA.



Press Release Body: Dr. Dabbagh's presentation will cover P38 MAP Kinases and the
important roles they play in inflammatory responses. Since P38 MAP Kinases are
involved in the generation, as well as the signaling pathways of pro-inflammatory
cytokines such as TNF- and IL-1, therapeutic targeting of P38 MAP
kinase has been an area of intense pre-clinical and clinical research. Dr.
Dabbagh's presentation will provide preclinical data for P38 inhibitors, the
selectivity profile of these inhibitors as well as the safety and efficacy of the
P38 inhibitors. The clinical applications of these inhibitors will also be
discussed.

GTCbio's 3rd Protein Kinase in Drug Discovery Conference will take place on May 5-6,
2008 in San Diego, CA and will cover Kinase Drug Design, Kinase Targets and
Inhibitors in CNS Disorders, Oncology, and Inflammatory Disorders, as well as New
Technologies in Screening and Identifying Targets and Inhibitors.

The conference also features presentations from other leading organizations such as
Johnson & Johnson, Roche, Pfizer, Merck, GlaxoSmithKline, Salk Institute,
AstraZeneca, Methylgene, UCSD, and many more. The full agenda is available online at
www.gtcbio.com.

For more information including a detailed agenda, exhibitor opportunities and
registration information visit http://gtcbio.com/userAgenda.aspx?id=121
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical
industries. Our goal is to facilitate the exchange of biopharmaceutical and
biomedical intelligence between industry leaders, academic and government
organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company
founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com


Web Site: http://www.gtcbio.com

Contact Details: Contact: GTCBIO 434 W Foothill Blvd. Monrovia, CA. 91016 (626)
256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •